2018_资讯搜索_第5页_商贸通_全球b2b电子商务贸易平台

2018-12-10 09:13“共创，展望”2018中国国际青年电影展盛大开幕

2018-12-10 09:13互联网域名注册数量在2018年第三季度增加到3.424亿

2018-12-07 09:51ExaGrid在2018 SVC大奖颁奖典礼上获评“年度超融合企业”

2018-12-07 09:51Sigma Systems首次进入2018年11月的Gartner配置、价格和报价应用套件魔力象限

Celgene Corporation Announces Initial Clinical Data from Ongoing Phase 1/2 Evolve Trial with Anti-BCMA CAR T Therapy JCARH125 in Relapsed/Refractory Multiple Myeloma at ASH 2018

2018-12-05 09:34穆迪分析荣获2018年度Regulation Asia卓越奖

2018-12-05 09:34Euromonitor International Reveals the World’s Top City Destinations in 2018

2018-12-05 09:34独立审计结果确认：2018亚洲消费电子展各项数据再创新高

Celgene Corporation Announces Initial Phase 1/2 Liso-cel Data in Patients with Relapsed/Refractory CLL, Including Those with High-Risk Disease, Previously Treated with Ibrutinib, at ASH 2018

Celgene Corporation and Acceleron Pharma Announce Results of the Phase 3 BELIEVE Trial Evaluating Luspatercept in Adult Patients with Beta-Thalassemia at ASH 2018

在供应找 2018

在求购找 2018

在公司库找 2018

在团购找 2018

在展会找 2018

在人才找 2018